Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-21-031104

Director bought 125,000 shares at $8.00 ($1,000,000)

  • Director acquired 283,514 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Martell Christopher Director 2021-07-29 Conversion +283,514 283,514 I
Martell Christopher Director 2021-07-29 Purchase +125,000 $8.00 $1,000,000 125,000 I
Derivatives
Martell Christopher Director 2021-07-29 Conversion · Series B Preferred Stock −696,851 0 I
Open-market purchases · 125,000 sh · avg $8.00 · $1,000,000
Loading xslF345X03/doc4.xml…